Supplementing Brief Psychotherapy With a Mobile App
2 other identifiers
interventional
40
1 country
1
Brief Summary
Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after discharge. Even among those who do attend therapy, however, the skills learned in treatment may be difficult to use during the highly distressing time leading up to and during a suicide crisis. Most traditional treatments are not designed to be effective during a suicide crisis. In order to reduce the risk of suicidal thoughts and behaviors in general and specifically during the post-discharge period, interventions are needed that: (1) are easily adhered to and (2) are accessible and effective during a suicide crisis. As such, the purpose of this research study is to test an innovative, new intervention in order to develop an effective and accessible intervention for those at high risk for suicide
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2023
CompletedFirst Posted
Study publicly available on registry
May 19, 2023
CompletedStudy Start
First participant enrolled
September 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2024
CompletedJune 13, 2025
June 1, 2025
8 months
April 3, 2023
June 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Suicidal thoughts
Within-person changes in momentary self-reported intensity of suicidal urges (measured on a 11-point rating scale via ecological momentary assessment) from pre- to post-EMI
Overall changes in momentary self-reported intensity of suicidal urges (on a 11-point scale up to 4x/ day via ecological momentary assessment) from pre- to post-EMI use, across the study period, which is approximately four weeks post discharge
Self-efficacy for managing negative emotion
Measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) self-efficacy for managing negative emotions scale. The scale is measured with four five-point scale items, summed to a score ranging from 4 to 20 where higher scores are better.
Beginning of study and end-of-study, approximately four weeks post discharge
Study Arms (1)
Unified Protocol
EXPERIMENTALUnified Protocol-based treatment, with three sessions
Interventions
Unified Protocol based treatment, modified for use in brief treatment on inpatient units
Eligibility Criteria
You may qualify if:
- Adult status (18+ years)
- Admission to eligible units in our partner hospital with a reason for admission having to do with suicide risk
- The ability to speak and write English fluently,
- Ownership of and consistent access to an internet-capable smartphone (e.g., an iPhone or Android phone)
You may not qualify if:
- \- The presence of any factor that impairs an individual's ability to provide informed consent and comprehend and effectively participate in the study including: an inability to speak or write English fluently, the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, or the presence of extremely agitated or violent behavior.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rutgers University Behavioral Healthcare
Piscataway, New Jersey, 08854, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Evan Kleiman
Rutgers, The State University of New Jersey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 3, 2023
First Posted
May 19, 2023
Study Start
September 14, 2023
Primary Completion
May 7, 2024
Study Completion
June 6, 2024
Last Updated
June 13, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE
- Time Frame
- Code will be shared within three months after manuscript publication.
We will share Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices)